drag_handle
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
YOLU Launches Skincare Inspired by Melatonin's Function, Japan's First* with Sleep-Friendly Fragrance! Night Cream and Serum to Guide You to 'Sleepy Beauty Skin'** Launch on August 1
YOLU has unveiled “YOLU SKIN,” a nighttime skincare brand inspired by the effects of melatonin.As Japan's first brand to incorporate a scent designed to support sleep environments, the “Moist” and “Clear” series will be released on August 1, 2025. Formulated with moisturizing ingredient PDRN and pore care ingredient azelaic acid derivative, the products help optimize nighttime skin conditions and promote a radiant complexion by morning. Free from parabens, alcohol, and other irritating ingredients, the products also feature sustainable packaging made from biomass PET.
FDA Grants Breakthrough Designation for Novel Bladder Cancer Diagnostic
The FDA has granted breakthrough device designation to the TOBY Test for bladder cancer. The TOBY Test is a urine-based test using artificial intelligence (AI) algorithms. This represents an easier and more accessible option for bladder cancer detection and monitoring compared with standard cystoscopy.
Cognitive Robotics and New Safety Technologies for Human-Robot Collaboration
Fraunhofer IFF has developed cognitive robotics and safety technologies that enable humans and robots to work together in automotive factories.This technology automates complex manufacturing tasks and enables dynamic workspace monitoring using AI. A new safety technology called PARU uses projection and cameras to monitor the workspace and ensure human safety. Additionally, CAS (Computer-Assisted Safety) is a software solution that enables efficient and safe execution of human-robot collaboration applications. These technologies will be showcased at the 2025 automotive exhibition.
LandSkip and Taisei Corporation conduct irradiation tests on “digital windows” for radiation therapy rooms
LandSkip Co., Ltd. (Representative Director: Kazuki Shimomura, hereinafter referred to as “LandSkip”), a provider of digital windows for medical institutions called “Medical Window,” has conducted irradiation tests for the introduction of “digital windows” into a linear accelerator room (radiation therapy room) as part of a joint project with Taisei Corporation (President and CEO: Yoshiro Aikawa, hereinafter referred to as “Taisei”).Through this test, the durability of key equipment was quantitatively evaluated, and safety standards for implementation were clarified. Moving forward, we will use these results to advance the full-scale implementation of the system in medical facilities.
Wearable sensors enable monitoring of treatment effects for sleep apnea syndrome
A software platform connected to a wearable pulse oximeter has been shown to be promising for monitoring sleep apnea. The platform was tested on 104 OSA patients as part of an ongoing clinical trial. As part of the trial, patients were asked to wear the device for 9 days out of 47, but 85% of patients wore it for longer than the recommended number of days.
Sky Labs at Forefront of Cuffless Blood Pressure Monitoring
Sky Labs, a South Korean digital healthcare startup, captured global attention at the European Society of Hypertension (ESH) 2025 in Milan, Italy, with the unveiling of the world’s first ring-type cuffless blood pressure monitor.
Microbial innovation into market reality – lessons from scale-up projects with CDMOs
Microbial fermentation has become a cornerstone of manufacturing across a wide range of industries, including food, cosmetics, and detergents, as demand for sustainable products continues to grow.However, scaling up from laboratory success to industrial-scale production presents numerous challenges, necessitating the optimization of scalable and efficient processes. As a result, many companies are partnering with CDMOs (Consulting, Development, and Manufacturing Organizations) to support the optimization of their manufacturing processes. ScaleUp Bio offers tailored infrastructure and multidisciplinary process development capabilities, enabling companies to focus on developing their own intellectual property.Process optimization focuses on improving yield, recovery rate, and reproducibility, and is carried out through an iterative and collaborative approach. Yield improvements directly contribute to cost reduction and regulatory compliance, thereby enhancing a company's competitiveness.In actual cases, ScaleUp Bio has collaborated with a European company to scale up the production of biodegradable oil to 10,000 liters and improve yield by 200%, and with an Asia-Pacific company to reduce unit costs by 88%. Furthermore, ScaleUp Bio operates GMP-compliant food-grade facilities, enabling seamless transition to regulatory compliance and market readiness.
Biological age test 'Epiclock® Test' surpasses 100 facilities in the number of handling medical institutions
The number of medical institutions offering Rhelixa Co., Ltd.'s biological age test, “Epiclock® Test,” has exceeded 100 nationwide as of early May 2025.This test analyzes DNA methylation patterns to visualize biological age and aging rates, supporting improvements in lifestyle and health conditions. It is expected to contribute to the advancement of personalized medicine and preventive healthcare. The company leverages epigenome analysis technology to conduct research and development, as well as provide services related to anti-aging. It plans to host a webinar for medical institutions on June 3, 2025.
Cellares and Mitsui Fudosan Announce the First IDMO Smart Factory for Commercial-Scale Cell Therapy Manufacturing in Japan
Cellares and Mitsui Fudosan have established Japan's first next-generation commercial production facility. This facility is an IDMO smart factory for large-scale manufacturing of cell therapy products such as CAR-T therapy, currently under construction in Kashiwa City, Chiba Prefecture. The facility will utilize Cellares' cutting-edge technologies, Cell Shuttle™ and Cell Q™, to reduce manufacturing costs by up to 50% and eliminate manufacturing bottlenecks.Additionally, the facility will create 350 jobs and improve access to treatment for patients in Japan and surrounding regions. The facility is scheduled to begin operations in 2024, with technology transfer enabled through software for rapid implementation. This project is expected to contribute to the advancement and accelerated approval of cell therapy in Japan.
Stopping the progression to frailty and making a significant contribution to the maintenance of the health of the elderly - Discovery of a biomarker for sarcopenia in the elderly -
A research group led by Professor Keiko Kato of the Faculty of Life Sciences at Kyoto Sangyo University, together with Dr. Tsune Kawai, Deputy Director of the Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, and Dr. Shuichi Ohbuchi, Director of the Institute of Gerontology, has discovered a new volatile urinary biomarker for detecting sarcopenia in the elderly. The results of this research will contribute to the early detection and prevention of sarcopenia, and in the future it is expected to have a wide range of applications, including frailty testing and the assessment of the efficacy of treatment drugs.
AI targeting food quality and safety. More accurate detection of contaminants and allergens to achieve compliance.
TraceGains announced the launch of its Intelligent Document Processing platform designed for food formulators to boost quality, performance and safety. It is built to help companies achieve Certificate of Analysis from food labs, ensuring their compliance with federal standards. The program is built on OpenAI’s model that TraceGains said provides “superior accuracy and reliability.” In a statement, the company said the program is more intelligent than previous platforms because it can flag deviations in a formula, such as allergens in flour. Food producers increasingly are using AI to pursue a higher potential for their food products’ taste, safety and health attributes.
Australia and New Zealand give green light to cultured meat, approve sale of Vow's cultured quail meat
Vow, a cultured meat company based in Sydney, Australia, has received the first sales approval from the Food Standards Australia New Zealand (FSANZ). This makes the company the first startup to receive regulatory approval for cultured meat in three or more regions.
University of Tokyo venture develops force-touch sensing system that acquires tactile data from muscle fiber movements
Commissure Co., Ltd. (Tokyo, Japan), a venture company spun off from the University of Tokyo, has developed a force-tactile sensing system called “SenseFuse™” utilizing its proprietary patented technology. SenseFuse™ estimates the force generated in the human hand by analyzing muscle fiber movements while simultaneously acquiring and streaming vibrations at the fingertips. The acquired force-tactile data can be reproduced using the company's force-tactile feedback system, “FeelFuse™.” A key feature of the system is its design, which does not cover the hand, enabling the collection of force-tactile data linked to interactions with objects without interfering with hand tracking.
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
DigitalMedical Open Innovation
デジタル・メディカル・オープンイノベーション
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future
of Health Care
OUR TECHNOLOGY HELPS
YOUR BUSINESS
Our technology will help your business
Technology
YOLU Launches Skincare Inspired by Melatonin's Function, Japan's First* with Sleep-Friendly Fragrance! Night Cream and Serum to Guide You to 'Sleepy Beauty Skin'** Launch on August 1
YOLU has unveiled “YOLU SKIN,” a nighttime skincare brand inspired by the effects of melatonin.As Japan's first brand to incorporate a scent designed to support sleep environments, the “Moist” and “Clear” series will be released on August 1, 2025. Formulated with moisturizing ingredient PDRN and pore care ingredient azelaic acid derivative, the products help optimize nighttime skin conditions and promote a radiant complexion by morning. Free from parabens, alcohol, and other irritating ingredients, the products also feature sustainable packaging made from biomass PET.
I-ne
FDA Grants Breakthrough Designation for Novel Bladder Cancer Diagnostic
The FDA has granted breakthrough device designation to the TOBY Test for bladder cancer. The TOBY Test is a urine-based test using artificial intelligence (AI) algorithms. This represents an easier and more accessible option for bladder cancer detection and monitoring compared with standard cystoscopy.
Targeted Oncology
Cognitive Robotics and New Safety Technologies for Human-Robot Collaboration
Fraunhofer IFF has developed cognitive robotics and safety technologies that enable humans and robots to work together in automotive factories.This technology automates complex manufacturing tasks and enables dynamic workspace monitoring using AI. A new safety technology called PARU uses projection and cameras to monitor the workspace and ensure human safety. Additionally, CAS (Computer-Assisted Safety) is a software solution that enables efficient and safe execution of human-robot collaboration applications. These technologies will be showcased at the 2025 automotive exhibition.
Fraunhofer Institute-Gesellschaft
LandSkip and Taisei Corporation conduct irradiation tests on “digital windows” for radiation therapy rooms
LandSkip Co., Ltd. (Representative Director: Kazuki Shimomura, hereinafter referred to as “LandSkip”), a provider of digital windows for medical institutions called “Medical Window,” has conducted irradiation tests for the introduction of “digital windows” into a linear accelerator room (radiation therapy room) as part of a joint project with Taisei Corporation (President and CEO: Yoshiro Aikawa, hereinafter referred to as “Taisei”).Through this test, the durability of key equipment was quantitatively evaluated, and safety standards for implementation were clarified. Moving forward, we will use these results to advance the full-scale implementation of the system in medical facilities.
PR TIMES
Wearable sensors enable monitoring of treatment effects for sleep apnea syndrome
A software platform connected to a wearable pulse oximeter has been shown to be promising for monitoring sleep apnea. The platform was tested on 104 OSA patients as part of an ongoing clinical trial. As part of the trial, patients were asked to wear the device for 9 days out of 47, but 85% of patients wore it for longer than the recommended number of days.
Physician's Weekly
Sky Labs at Forefront of Cuffless Blood Pressure Monitoring
Sky Labs, a South Korean digital healthcare startup, captured global attention at the European Society of Hypertension (ESH) 2025 in Milan, Italy, with the unveiling of the world’s first ring-type cuffless blood pressure monitor.
Businesswire
Microbial innovation into market reality – lessons from scale-up projects with CDMOs
Microbial fermentation has become a cornerstone of manufacturing across a wide range of industries, including food, cosmetics, and detergents, as demand for sustainable products continues to grow.However, scaling up from laboratory success to industrial-scale production presents numerous challenges, necessitating the optimization of scalable and efficient processes. As a result, many companies are partnering with CDMOs (Consulting, Development, and Manufacturing Organizations) to support the optimization of their manufacturing processes. ScaleUp Bio offers tailored infrastructure and multidisciplinary process development capabilities, enabling companies to focus on developing their own intellectual property.Process optimization focuses on improving yield, recovery rate, and reproducibility, and is carried out through an iterative and collaborative approach. Yield improvements directly contribute to cost reduction and regulatory compliance, thereby enhancing a company's competitiveness.In actual cases, ScaleUp Bio has collaborated with a European company to scale up the production of biodegradable oil to 10,000 liters and improve yield by 200%, and with an Asia-Pacific company to reduce unit costs by 88%. Furthermore, ScaleUp Bio operates GMP-compliant food-grade facilities, enabling seamless transition to regulatory compliance and market readiness.
FoodNavigator
Biological age test 'Epiclock® Test' surpasses 100 facilities in the number of handling medical institutions
The number of medical institutions offering Rhelixa Co., Ltd.'s biological age test, “Epiclock® Test,” has exceeded 100 nationwide as of early May 2025.This test analyzes DNA methylation patterns to visualize biological age and aging rates, supporting improvements in lifestyle and health conditions. It is expected to contribute to the advancement of personalized medicine and preventive healthcare. The company leverages epigenome analysis technology to conduct research and development, as well as provide services related to anti-aging. It plans to host a webinar for medical institutions on June 3, 2025.
PR TIMES
Cellares and Mitsui Fudosan Announce the First IDMO Smart Factory for Commercial-Scale Cell Therapy Manufacturing in Japan
Cellares and Mitsui Fudosan have established Japan's first next-generation commercial production facility. This facility is an IDMO smart factory for large-scale manufacturing of cell therapy products such as CAR-T therapy, currently under construction in Kashiwa City, Chiba Prefecture. The facility will utilize Cellares' cutting-edge technologies, Cell Shuttle™ and Cell Q™, to reduce manufacturing costs by up to 50% and eliminate manufacturing bottlenecks.Additionally, the facility will create 350 jobs and improve access to treatment for patients in Japan and surrounding regions. The facility is scheduled to begin operations in 2024, with technology transfer enabled through software for rapid implementation. This project is expected to contribute to the advancement and accelerated approval of cell therapy in Japan.
BioSpace
Stopping the progression to frailty and making a significant contribution to the maintenance of the health of the elderly - Discovery of a biomarker for sarcopenia in the elderly -
A research group led by Professor Keiko Kato of the Faculty of Life Sciences at Kyoto Sangyo University, together with Dr. Tsune Kawai, Deputy Director of the Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, and Dr. Shuichi Ohbuchi, Director of the Institute of Gerontology, has discovered a new volatile urinary biomarker for detecting sarcopenia in the elderly. The results of this research will contribute to the early detection and prevention of sarcopenia, and in the future it is expected to have a wide range of applications, including frailty testing and the assessment of the efficacy of treatment drugs.
京都産業大学
AI targeting food quality and safety. More accurate detection of contaminants and allergens to achieve compliance.
TraceGains announced the launch of its Intelligent Document Processing platform designed for food formulators to boost quality, performance and safety. It is built to help companies achieve Certificate of Analysis from food labs, ensuring their compliance with federal standards. The program is built on OpenAI’s model that TraceGains said provides “superior accuracy and reliability.” In a statement, the company said the program is more intelligent than previous platforms because it can flag deviations in a formula, such as allergens in flour. Food producers increasingly are using AI to pursue a higher potential for their food products’ taste, safety and health attributes.
FOODDIVE
Australia and New Zealand give green light to cultured meat, approve sale of Vow's cultured quail meat
Vow, a cultured meat company based in Sydney, Australia, has received the first sales approval from the Food Standards Australia New Zealand (FSANZ). This makes the company the first startup to receive regulatory approval for cultured meat in three or more regions.
Framtiden
University of Tokyo venture develops force-touch sensing system that acquires tactile data from muscle fiber movements
Commissure Co., Ltd. (Tokyo, Japan), a venture company spun off from the University of Tokyo, has developed a force-tactile sensing system called “SenseFuse™” utilizing its proprietary patented technology. SenseFuse™ estimates the force generated in the human hand by analyzing muscle fiber movements while simultaneously acquiring and streaming vibrations at the fingertips. The acquired force-tactile data can be reproduced using the company's force-tactile feedback system, “FeelFuse™.” A key feature of the system is its design, which does not cover the hand, enabling the collection of force-tactile data linked to interactions with objects without interfering with hand tracking.
METAPICKs